Co-Authors
This is a "connection" page, showing publications co-authored by SHALINI DALAL and ALI HAIDER.
Connection Strength
0.841
-
Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic. Cancer. 2019 Dec 15; 125(24):4525-4531.
Score: 0.174
-
Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. JAMA Oncol. 2019 Jun 01; 5(6):841-846.
Score: 0.171
-
Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids. J Pain Symptom Manage. 2024 Dec; 68(6):e500-e507.
Score: 0.062
-
Impact of an Institution-Wide Goals of Care Program on the Timing of Referrals to Outpatient Palliative Care. J Pain Symptom Manage. 2023 12; 66(6):e666-e671.
Score: 0.057
-
Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. J Pain Symptom Manage. 2023 06; 65(6):e683-e690.
Score: 0.055
-
Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. J Palliat Med. 2022 Oct; 25(10):1557-1562.
Score: 0.053
-
A retrospective review of the use of oxymorphone immediate release for long term pain control in cancer patients with gastrostomy tubes. Ann Palliat Med. 2021 Mar; 10(3):2662-2667.
Score: 0.048
-
Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer. 2021 03 15; 127(6):968-975.
Score: 0.047
-
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol. 2020 07; 21(7):989-998.
Score: 0.046
-
Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers (Basel). 2020 Jan 15; 12(1).
Score: 0.045
-
Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage. 2019 10; 58(4):605-613.
Score: 0.043
-
Personalized Pain Goal as an Outcome Measure in Routine Cancer Pain Assessment. J Pain Symptom Manage. 2018 07; 56(1):80-87.
Score: 0.039